Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Sectoral/ Thematic median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 21 Feb 2024 – 20 Aug 2026, limited by quant PSU Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | quant PSU Fund | Nifty 500 |
|---|---|---|
| 21 Feb 2024 | ₹100.00 | ₹100.00 |
| 07 May 2024 | ₹103.53 | ₹102.52 |
| 22 Jul 2024 | ₹124.43 | ₹113.98 |
| 06 Oct 2024 | ₹118.96 | ₹116.92 |
| 21 Dec 2024 | ₹102.18 | ₹110.89 |
| 07 Mar 2025 | ₹92.25 | ₹101.57 |
| 22 May 2025 | ₹101.96 | ₹112.25 |
| 05 Aug 2025 | ₹99.52 | ₹113.27 |
| 20 Oct 2025 | ₹102.37 | ₹117.82 |
| 04 Jan 2026 | ₹105.13 | ₹119.73 |
| 21 Mar 2026 | ₹93.13 | ₹105.96 |
| 05 Jun 2026 | ₹107.99 | ₹111.61 |
| 20 Aug 2026 | ₹104.94 | ₹116.82 |
| Metric | quant · Regular · IDCW NAV ₹10.49 Very High risk ★★★☆☆ 1Y | Category median Sectoral/ Thematic · 248 funds |
|---|---|---|
| +6.09% | +3.54% | |
| — | +11.47% | |
| — | +9.70% | |
| — | +10.32% | |
| +1.95% | +9.15% | |
| +0.52% | — | |
| — | +12.10% | |
| — | +10.32% | |
| — | +8.80% | |
| Risk | ||
| 22.71% | 15.91% | |
| -0.02 | 0.25 | |
| -0.02 | 0.32 | |
| -31.64% | -26.14% | |
| Nifty 500 | — | |
| -3.06% | -0.04% | |
| 1.39 | 0.98 | |
| 119.8% | 98.3% | |
| 152.1% | 101.5% | |
| 3.57% | 2.38% | |
| ₹485.56Cr | ₹1,160Cr | |
| 1.00% | — | |
| None | — | |
| ₹1.00K | — | |
| ₹5.00K | — | |
| — | 42% | |
| Sandeep Tandon · 2.5y | — | |
| 21 Feb 2024 | — | |
| 10 | — | |
| 79.4% | — | |
| -3.5% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.